Unimark Remedies Limited

About Us

To create and sustain value with a deeply embedded corporate culture of Commitment, Core Value, Integrity and Continuous search for excellence.

To be sought after as best employer and well respected by the business community and by our competitors.

1983 :Started as a Marketing Company
1995 :Backward integration with API manufacturing
1997 :Acquired Antibiotic facility at Bavla (Ahmedabad)
2006 :Vapi Manufacturing plant received US FDA approval
2007 :Bavla Manufacturing plant received US FDA approval
2008 :Commissioned a new dedicated facility for Carbapenem.
Oncology facility (for high potency compounds) under execution
Acquired majority stake in KDL Biotech Ltd.